This site uses cookies to store information on your computer. Learn more x

TalkingNutrition

Providing perspectives on recent research into vitamins and nutritionals

Cau_soldier_helicopter_helmet

EFSA Finds no Safety Concerns with Algal EPA and/or DHA and Increases Upper Intake Level

By Michael McBurney

Experts from the European Food Safety Authority (EFSA) published a scientific opinion that supplemental DHA and EPA from algal oil sources (Schizochytrium species) can be safely increased from 3 grams daily to 5 grams daily as there is no safety concerns for adults.

The committee also reviewed evidence for an association between EPA and DHA intake in the development of prostate cancer. They found no evidence. In the VITAL cohort, Brasky et al reported that fish oil omega-3 supplement use was not associated with prostate cancer risk. Later, using data from the SELECT trial, Brasky et al reported EPA and DHA concentrations increased prostate cancer risk. However, Harris and Davidson criticized the authors for inappropriately extrapolating the data when blood concentrations were well below those seen in individuals taking fish oil supplements.  A single baseline blood samples is also not an accurate reflection of long-term omega-3 intake or status.

Clearly, experts at EFSA have concluded there are no risks associated with DHA and/or EPA supplementation from algal oils as they increased the safe supplemental intake level from 3 to 5g daily.

Main Citation

Scientific opinion on the extension of use for DHA and EPA-rich algal oil from Schizochytrium sp. as a novel food ingredient. 2014 EFSA J doi: 10.2903/j.efsa.2014.3843

Other Citations

Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens Jr FL, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. 2013 J Natl Cancer Inst doi: 10.1093/jnci/djt174

Brasky, TM, Kristal AR, Navarro SL, Lampe JW, Peters U, Patterson RE, White E. Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort. 2011 Nutr Cancer 10.1080/01635581.2011.553022

Harris W, Davidson MH. . Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. 2014 J Natl Cancer Inst  doi: 10.1093/jnci.dju019


You are signed in as:
 
 
 
4comments
aguillou@odontella.com
GUILLOU August 21, 2017 10:11 AM
Hello,

I would like to know the name of the company that is selling your Schizochytrium oils rich in DHA in France. Thank you.

A. GUILLOU Ph.D.
0 Replies » Reply
leminhtan242000@gmail.com
sâm hàn quốc September 9, 2017 6:18 AM
Cửa Hàng Sâm Yến Thịnh Phát xin giới thiệu các loại bánh trung thu yến sào 2017 đặc biệt thơm ngon
0 Replies » Reply
Cửa Hàng Sâm Yến Thịnh Phát xin giới thiệu các loại bánh trung thu yến sào 2017 đặc biệt thơm ngon. Bánh trung thu yến sào bán tại cửa hàng là sản phẩm của công ty nhà nước Yến Sào Khánh Hòa.
0 Replies » Reply
Công dụng của nhân sâm đối với sức khỏe con người
Theo Đông y, nhân sâm là dược liệu quý hiếm có vị đắng, không độc, có tác dụng đại bổ nguyên khí, giúp bồi bổ sức khỏe, nâng cao thể lực cho con người. Khoa học phát triển, các nhà nghiên cứu đã tìm ra những công dụng tốt của nhân sâm với cơ thể. Dưới đây là một số công dụng mà nhân sâm mang đến cho cơ thể.
Tăng cường sức khỏe, bồi bổ cơ thể
0 Replies » Reply
Logo